Hard to quantify a value here...
But with a market cap still under $15m, given the significance of some of their area's of work, especially the 100% owned Bacterial DNA test, it would appear the upside is not limited by an overvalued share price, rather it is simply being held back by profit takers.
Very tight share structure, resulting in relatively few in the market...so profit taking would not be expected to last forever.
As such, this thing could well double in a relatively short period of time...and still not be expensive in my opinion.
Cheers!
Hard to quantify a value here...But with a market cap still...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BPH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.002(10.5%) |
Mkt cap ! $24.09M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $74.36K | 3.717M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 825986 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 2014404 | 13 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BPH (ASX) Chart |